Project description
Funding the CEPI vaccine against COVID-19
As the COVID-19 pandemic puts billions of lives at risk and takes a big toll on the global economy, many are rushing to develop a vaccine against the disease. With millions of deaths reported worldwide, all efforts directed towards the development of a vaccine are essential. To this end the EU-funded COVID-19 VACCINES project aims to acquire co-funding from the European Commission in support of vaccine development efforts by the Coalition for Epidemic Preparedness Innovations (CEPI). It is seeking programmes concerning research and development of vaccines that would allow for accessibility by as many people as possible.
Objective
Funding of research and innovation programmes for the development of novel SARS-CoV-2 vaccine against COVID-19 disease
The overall objective is to leverage co-funding from the European Commission to support CEPI’s COVID-19 vaccine programme development efforts. The COVID-19 outbreak has in a short timeframe grown to a global pandemic of historic proportions, with detrimental humanitarian and economic consequences. All evidence now suggests that eradication of COVID-19 is not feasible and that we face a global public health crisis which is unprecedented in modern times. Investing in vaccine development now is an investment in the future health for all in our societies and a return to social and economic development – both in Europe and in the rest of the globe.
CEPI is seeking to support scientifically excellent research and development vaccine development programmes of a nature that will allow the broadest global access of the vaccines that are ultimately developed both within the current pandemic crisis and beyond. This will help curb the current ongoing outbreak, that is resulting in human suffering and a grave global economic crisis. CEPI was set up to respond to the crisis, where our vision is a world in which epidemics are no longer a threat to humanity. Our strategic objectives are further aligned with the sustainable
development goals 3, 8 and 17. Of particular importance to CEPI’s work is to try and ensure that low- and low-middle income countries (LICs and LMICs, respectively) will have access to the vaccines to protect their most vulnerable population, as soon as a vaccine is made available and irrespective of their ability to pay. As the current pandemic has shown, viruses respect no borders. To successfully curb the COVID-19 pandemic and beyond, we must ensure that all countries have the necessary tools to control the outbreak domestically. No-one is safe until everyone is safe.
Fields of science
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
Programme(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
0277 OSLO
Norway